First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors

NCT03429218 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: TP-0184

Sponsor

Sumitomo Pharma America, Inc.